Genetica

Canopy Growth Q3 revenue soars but so does its loss from operations

Published Feb 15, 2019 11:57 a.m. ET
Staff work in a marijuana grow room that can be viewed by at the new visitors centre at Canopy Growths Tweed facility in Smiths Falls, Ontario on Thursday, Aug. 23, 2018. Canopy Growth Corp. says it generated $97.7 million of revenue in the three months ended Dec. 31, including its first sales of non-medical cannabis products, up from $21.7 million in the previous year's fiscal third quarter. THE CANADIAN PRESS/Sean Kilpatrick

SMITHS FALLS, Ont. — Canopy Growth Corp. says it generated $97.7 million of revenue in the three months ended Dec. 31, including its first sales of non−medical cannabis products, up from $21.7 million in the previous year’s fiscal third quarter.

The Ontario−based company — one of Canada’s largest cannabis producers — recorded a loss from operations for the quarter, but turned a net profit due to gains on the fair value of its assets and liabilities.

Loss from operations was $157.2 million, compared with a loss of $26 million a year earlier.

Net income attributable to shareholders, including net gains on the fair value of its assets, was $67.6 million or 22 cents per basic share, up from $1.6 million or one cent per basic share a year earlier.

Adjusted EBITDA (earnings before taxes, depreciation and amortization) was negative $75.1 million, compared with a year earlier adjusted loss of $5.68 million.

Genetica

Canopy also reported that if all of its convertible debt had been converted to equity at the beginning of the quarter, it would have had a net loss of 38 cents per diluted share.

The company said Tim Saunders has decided to retire as chief financial officer later this year after assisting with the transition to a new CFO, but will remain on the board of directors as a strategic adviser.

Companies in this story: (TSX:WEED)

The Canadian Press

Genetica

Author

Related posts